You are viewing: India Compounding Pharmacy Market analysis
Part of: Compounding Pharmacy Market (Global)

The India Compounding Pharmacy Market was valued at $177.4 Million in 2025 and projected to reach to $257.2 Million by 2030, representing a compound annual growth rate of CAGR 7.7%. India's compounding pharmacy market is positioned for sustained growth over the forecast period, driven by increasing healthcare expenditure, growing middle-class population, and rising awareness of personalized medicine benefits.

India Compounding Pharmacy Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

India Compounding Pharmacy Market Trends and Insights

  • This expansion in India reflects increasing demand for personalized medication solutions, driven by rising healthcare awareness and a growing patient preference for customized pharmaceutical formulations.
  • India's compounding pharmacy sector is benefiting from regulatory support and the expansion of specialized healthcare facilities across urban and semi-urban regions. The market dynamics in India are shaped by several factors including the rising prevalence of chronic diseases, an aging population, and the need for alternative dosage forms that cater to specific patient requirements.
  • India's compounding pharmacies are increasingly adopting advanced technologies and quality standards to meet international benchmarks.
  • Between 2025 and 2030, India is expected to witness significant investments in infrastructure and skilled workforce development, positioning the country as a key player in the Asia Pacific compounding pharmacy landscape..

Key Market Statistics

  • CAGR (2025-2030) CAGR 7.7%
  • Market Size, 2025 ~USD 177.4 Million
  • Forecast, 2030 ~USD 257.2 Million
  • Country India

India Compounding Pharmacy Market Overview

Market Valuation & Growth :

India's compounding pharmacy market is valued at USD 177.4 million in 2025 and is projected to reach USD 257.2 million by 2030, demonstrating a strong CAGR of 7.7%, outpacing the global growth rate of 5.7%.

Personalized Medicine Demand :

Rising healthcare awareness and increasing patient preference for customized pharmaceutical solutions are driving significant demand for compounded medications across India's urban and semi-urban healthcare segments.

Healthcare Infrastructure Expansion :

India's growing network of specialty pharmacies, coupled with improved regulatory frameworks and increased investment in pharmaceutical infrastructure, is creating favorable conditions for compounding pharmacy expansion.

Chronic Disease Management :

The rising prevalence of chronic diseases and lifestyle disorders in India is fueling demand for tailored medication formulations that address specific patient needs and improve treatment outcomes.

India Compounding Pharmacy Market Dynamics

  • The market's 7.7% CAGR reflects strong demand from both urban healthcare facilities and emerging tier-2 and tier-3 cities seeking customized pharmaceutical solutions. Key growth catalysts include regulatory support for quality compounding practices, expansion of specialty healthcare services, and rising patient preference for tailored medications over mass-produced alternatives.
  • As India's healthcare sector continues to modernize and digitalize, compounding pharmacies are expected to play an increasingly vital role in delivering patient-centric care and improving medication efficacy across diverse therapeutic areas..

Market Ecosystem

logo-mobile

COMPOUNDING PHARMACY MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
company logo
Provides sterile and non-sterile compounding services, including ready-to-dispense and ready-to-administer personalized medicines for pharmacies, hospitals, and clinics | Its compounding operations support customized strengths, dosage forms, ingredient requirements, and therapies where commercially available medicines may be unsuitable or unavailable. Enables healthcare providers to address patient-specific medication requirements, drug shortages, discontinued products, allergies, and dosage-form limitations while outsourcing complex sterile and non-sterile compounding activities.
company logo
Operates both a 503A compounding pharmacy for patient-specific prescriptions and an FDA-registered 503B outsourcing facility for office-use medications | Its portfolio includes compounded preparations across multiple therapeutic areas and dosage forms, supported by sterile batch testing and cGMP processes at the 503B facility. Expands access to individualized medicines and multiple strengths and dosage forms while enabling healthcare providers to procure larger-scale compounded products from a regulated outsourcing facility.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

Related Ecosystem

Pharmaceuticals

Top Technologies
  • Bioreactors
  • Analytical Testing
  • Bioanalytical Testing Services
  • Cell Counters
  • Data Management Services
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • SANOFI
  • Pfizer Inc.
  • NOVARTIS

    Key Takeaways

    • India's compounding pharmacy market is valued at USD 177.4 million in 2025 and is forecast to reach USD 257.2 million by 2030.
    • India demonstrates a strong CAGR of 7.7% over the forecast period, outpacing global growth trends.
    • India's market growth is driven by increasing demand for personalized medications and chronic disease management solutions.
    • India is investing in regulatory compliance and advanced technologies to strengthen its position in the Asia Pacific compounding pharmacy sector.

    Compounding Pharmacy Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment HORMONE REPLACEMENT THERAPIES (Therapeutic Application)
    Forecast Period 2025–2030
    Growth Rate CAGR of 5.7% from 2025 to 2030
    Largest Segment PHARMACEUTICAL DOSAGE ALTERATION (Compounding Type)
    Market Size Base Year (Billions) ~USD 14.71 (2025)
    Revenue Forecast (Billions) ~USD 19.41 (2030)
    Segments Covered Product, Compounding Type, Therapeutic Application

    India Compounding Pharmacy Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Product

    • Nasal Drugs
    • Ophthalmic Drugs
    • Oral Drugs
    • Other Products
    • Parenteral Drugs
    • Rectal Drugs
    • Topical Drugs

    By Compounding Type

    • Currently Unavailable Pharmaceutical Manufacturing
    • Pharmaceutical Dosage Alteration
    • Pharmaceutical Ingredient Alteration

    By Therapeutic Application

    • Dermal Disorders
    • Hormone Replacement Therapies
    • Nutritional Supplements
    • Other Therapeutic Applications
    • Pain Management

    INDIA: COMPOUNDING PHARMACY MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    ADULTS237.4269.7299.9328353.7377.7403.6432.67.6
    GERIATRIC PATIENTS102.9116128138.9148.6157.4166.9177.56.8
    PEDIATRIC PATIENTS74.685.896.7107116.9126.3136.7148.38.9
    TOTAL414.9471.4524.6574619.1661.4707.1758.37.6

    Target Audience

    • Pharmaceutical Companies : Pharmaceutical manufacturers and distributors need India-specific market data to develop localized compounding strategies, identify partnership opportunities, and optimize product portfolios for the growing personalized medicine segment.
    • Healthcare Investors : Private equity firms, venture capitalists, and healthcare investors require detailed India market analysis to evaluate investment opportunities in compounding pharmacy chains and assess growth potential and ROI projections.
    • Pharmacy Operators & Chains : Existing and prospective pharmacy operators need market insights to understand competitive positioning, expansion opportunities, and customer demand patterns specific to India's compounding pharmacy sector.
    • Healthcare Consultants : Management consultants and healthcare advisors require India-specific market data to provide strategic recommendations to clients on market entry, competitive strategies, and operational optimization in compounding pharmacy.
    • Regulatory & Policy Bodies : Government agencies, healthcare regulators, and policy makers need market intelligence on India's compounding pharmacy sector to develop informed regulations, quality standards, and healthcare policies supporting sector growth.

    Key Companies in the India Compounding Pharmacy Market

    CompanyHQOwnershipStrongest segments
    BAXTERUnited StatesPublic CompanyMedical Products & Therapies (IV, infusion, parenteral nutrition, renal-related therapies),Healthcare Systems & Technologies (smart beds, monitoring, OR integration, surgical equipment),Pharmaceuticals (generic and specialty injectables, inhaled anesthetics, compounding services),
    FAGRONBelgiumPublic CompanyEssentials (APIs, excipients, bases),Brands (derma, immunology, hair, scar care),Compounding Services,

    BAXTER

    Baxter is a publicly traded American healthcare company founded in 1931 that employs 37,500 people. The company operates as a major medical device and pharmaceutical manufacturer serving global markets.

    FAGRON

    Fagron is a publicly traded Belgian pharmaceutical company founded in 1990 with 4,880 employees. The company focuses on pharmaceutical compounding and specialty pharmacy solutions.

    Reasons to Buy this Report

    • Market Size & Growth Validation : Obtain precise market valuation data for India's compounding pharmacy sector with verified CAGR of 7.7%, enabling accurate financial forecasting and investment decision-making for the 2025-2030 period.
    • Competitive Landscape Intelligence : Understand India-specific market dynamics, key players, and competitive positioning within the compounding pharmacy space to identify growth opportunities and strategic partnerships in this high-growth segment.
    • Regulatory & Compliance Insights : Access India-specific regulatory frameworks, quality standards, and compliance requirements for compounding pharmacies to ensure market entry strategies align with local healthcare regulations and operational best practices.
    • Customer Demand Analysis : Gain deep insights into India's patient demographics, healthcare preferences, and demand drivers for personalized medications to tailor product offerings and marketing strategies for maximum market penetration.
    • Investment & Expansion Strategy : Leverage comprehensive India market data to develop informed expansion strategies, identify high-potential geographic markets, and allocate resources effectively across India's diverse healthcare ecosystem.

    Frequently asked questions

    What is the current size of India's compounding pharmacy market?

    India's compounding pharmacy market is valued at USD 177.4 million in 2025.

    What is the projected market size for India's compounding pharmacy sector by 2030?

    India's compounding pharmacy market is projected to reach USD 257.2 million by 2030.

    What is the CAGR for India's compounding pharmacy market?

    India's compounding pharmacy market is expected to grow at a CAGR of 7.7% from 2025 to 2030.

    What factors are driving growth in India's compounding pharmacy market?

    Growth in India is driven by rising healthcare awareness, increasing prevalence of chronic diseases, demand for personalized medications, and regulatory support for specialized pharmaceutical services.

    How does India's compounding pharmacy market compare to global trends?

    India's CAGR of 7.7% exceeds the global CAGR of 5.7%, indicating faster market expansion and strong regional demand for compounding pharmacy services.

    RESEARCH METHODOLOGY

    This study involved four major activities to estimate the current size of the compounding pharmacy market. We conducted exhaustive secondary research to gather information on the market, its peer markets, and its parent market. The team then validated these findings, assumptions, and sizing with industry experts across the value chain through primary research. We used both top-down and bottom-up approaches to estimate total market size. We then used data triangulation to estimate market size by segment and subsegment.

    Secondary Research

    Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the compounding pharmacy market. The secondary sources used for this study include US Food and Drug Administration (FDA), American Pharmacists Association (APhA), International Academy of Compounding Pharmacists (IACP), National Community Pharmacists Association (NCPA), Parenteral Drug Association (PDA), American Society of Health-System Pharmacists (ASHP), Pharmacy Compounding Accreditation Board (PCAB), European Directorate for the Quality of Medicines & HealthCare (EDQM), European Medicines Agency (EMA), International Pharmaceutical Federation (FIP), Journal of Compounding & Specialty Pharmacy (JCSP), National Center for Biotechnology Information (NCBI), Pharmaceutical Research and Manufacturers of America (PhRMA), Pharma & Biopharma Outsourcing Association (PBOA), and World Journal of Pharmaceutical Research (WJPR). Secondary sources also include corporate and regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; trade, business, and professional associations; and MarketsandMarkets Analysis. These sources were also used to obtain key information on major players, market classification, and segmentation based on industry trends, regional/country-level markets, market developments, and technology perspectives.

    Primary Research

    We conducted in-depth interviews with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and assess market prospects. We interviewed primary sources from both the supply and demand sides of the market to gather qualitative and quantitative data. The following is a breakdown of the primary respondents:

    Compounding Pharmacy Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    We estimated the global size of the compounding pharmacy market using multiple approaches. We used a detailed market estimation approach to estimate and validate the market value and other dependent submarkets. We also used these methods extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following.

    Compounding Pharmacy Market: Top-Down and Bottom-Up Approach

    Compounding Pharmacy Market Top Down and Bottom Up Approach

    Data Triangulation

    After estimating the market size using the process described above, we divided the total market into several segments and subsegments. To complete the overall market analysis and obtain precise statistics for all segments and subsegments, we used data triangulation and market breakdown methods where applicable. We triangulated the data by examining factors and trends from both the demand and supply sides.

    Market Definition

    A compounding pharmacy is a specialized practice in which a licensed pharmacist combines, mixes, or alters raw drug ingredients to formulate customized medications tailored to individual patients' unique health needs. This process allows pharmacists to create pharmaceutical products in various forms, such as liquids, creams, gels, or capsules, and can be vital for patients with specific allergies, intolerances, or those needing dosages not commercially available. Compounding pharmacists often work closely with healthcare providers to develop formulas that address particular medical conditions, ensuring that each preparation is safe, effective, and personalized to optimize patient care. Additionally, compounding pharmacies adhere to stringent regulatory standards to maintain the integrity and quality of the medications they produce.

    Key Stakeholders

    • Pharmaceutical & Biotechnology Companies
    • Compounding Pharmacies
    • Research & Consulting Firms
    • Academic Medical Centers
    • Government Regulatory & Research Organizations
    • Quality Assurance & Accreditation Bodies
    • Clinical Research Institutes

    Report Objectives

    • To define, describe, and forecast the compounding pharmacy market based on product, compounding type, therapeutic application, sterility, end user, and region
    • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall compounding pharmacy market
    • To analyze opportunities for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments with respect to five regions: North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, and the Rest of Latin America), and the Middle East & Africa (GCC Countries and the Rest of Middle East & Africa)
    • To profile the key players and analyze their market share and core competencies
    • To analyze competitive developments, such as product launches, partnerships, agreements, collaborations, and expansions
    • To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy

    Available customizations:

    With the given market data, MarketsandMarkets offers customization as per the company’s specific needs. The following options are available for the report:

    Geographical Analysis

    • A further breakdown of the Rest of Asia Pacific compounding pharmacy market into countries
    • A further breakdown of the Rest of Europe compounding pharmacy market into countries
    • A further breakdown of the Rest of Latin America compounding pharmacy market into countries

    Company Information

    • Detailed analysis and profiling of additional market players (up to five).
     

     

    Get the Full Compounding Pharmacy Market Report

    Full forecast, segment splits, and company analysis for all Compounding Pharmacy Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status